Technology News and Research

RSS

New decade of vaccines

This Lancet series examines vaccine technology, including the developments expected over the coming decade and what we can expect from translation of the latest vaccine science.

13 Jun 2011

Human adult and embryonic stem cell research can benefit medical science, researchers say

New research says studying both adult and embryonic stem cells can benefit medical science, but banning the study of either type could harm studies of the other.

13 Jun 2011

STCEID to establish Center of Excellence in Infection Genomics

The South Texas Center for Emerging Infectious Diseases at The University of Texas at San Antonio announced today it will receive $4.6 million over the next five years from the U.S. Department of Defense's Army Research Office to establish a Center of Excellence in Infection Genomics to support microbiology research, teaching and outreach activities aligned with Army priorities.

13 Jun 2011

Hanwha, Merck partner to develop and commercialize HD203

Merck, known as MSD outside the United States and Canada, and Hanwha Chemical Corporation today announced that they have entered into an exclusive global agreement to develop and commercialize a candidate biosimilar form of Enbrel.

13 Jun 2011

ACS honors Los Angeles general surgeon with 2011 Jacobson Innovation Award

George Berci, MD, FACS, FRCS, Ed. (Hon), a general surgeon from Los Angeles, CA, is the recipient of the 2011 Jacobson Innovation Award of the American College of Surgeons.

13 Jun 2011

Scientists pioneer way to find more chromosomal aberrations in tumors

Washington University Pediatric Cancer Genome Project scientists pioneer way to find more chromosomal aberrations in tumors; results likely to advance understanding of cancer.

13 Jun 2011

Kurma, CRT launch BliNK Therapeutics to generate monoclonal antibodies

Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.

13 Jun 2011

New opportunities to save another 6.4 million lives

Vaccinating children around the world against infectious diseases has saved the lives of millions over the past several decades. Now new opportunities exist to overcome remaining challenges-and save another 6.4 million lives over the current decade, according articles in the June 2011 edition of Health Affairs. The issue was produced under the journal's grant from the Bill & Melinda Gates Foundation.

10 Jun 2011

Legislation that slows human embryonic stem cell research will also harm iPS cells study

Any legislation that slows human embryonic stem cell research is likely to also seriously harm the study of induced pluripotent stem cells, according to a new study by researchers at the Stanford University School of Medicine, the Mayo Clinic and the University of Michigan.

10 Jun 2011

IMS Health acquires Med-Vantage

IMS Health has acquired Med-Vantage, a San Francisco-based software solutions company, to further expand its presence and capabilities in the payer marketplace. Med-Vantage offers its clients a comprehensive suite of provider performance management and member engagement solutions that promote high-quality care and address the complexities of new reimbursement and care delivery models.

10 Jun 2011

GE and Mayo Clinic receive $5.7 million NIH grant to study dedicated MRI brain scanner technology

Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company, and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of Neurological Disorders and Stroke (NINDS), components of the National Institutes of Health.

10 Jun 2011

Large medical groups urge OMB to be careful with ACO budget expectations

The American Group Management Association asked the Obama administration to scale back the anticipated savings that are expected from the creation of accountable care organizations. Setting the savings bar too high, the organizations said, could cause the ACO program to be unsuccessful.

10 Jun 2011

NIOSH grants Noveko N95 certification for RD5-V respirator

Noveko International Inc. is pleased to announce that its subsidiary Noveko Inc. has obtained N95 certification from the U.S. National Institute for Occupational Safety and Health ("NIOSH") for its Noveko RD5-V respirator.

10 Jun 2011

Revance closes $45 million financing

Revance Therapeutics, Inc. today announced the closing of a $45 million financing led by Essex Woodlands Health Ventures and new investor, NovaQuest Capital.

10 Jun 2011

Life Technologies enters exclusive agreement for TAL Effector Technology license

Life Technologies Corporation has signed an exclusive license agreement for novel technology that enables synthetic biologists to effectively program and control the genetic circuitry in engineered pathways and organisms.

10 Jun 2011

Ambit Biosciences raises $30 million through Series D-2 equity financing

Ambit Biosciences (Ambit), an emerging biopharmaceutical company engaged in the development of kinase inhibitors for the treatment of cancer and other conditions, today announced that it has completed a Series D-2 round of equity financing, raising $30 million in new capital.

10 Jun 2011

Spanish scale measures concern about cancer in healthy people

When a person has a family history of cancer, their worry about developing the disease may lead to them refusing to have preventive tests. Advice from genetic counselling units reduces their anxiety but, until now, nobody knew how much. Now, a scientific team has validated the 'Escala de Preocupaci-n por el C-ncer - EPC' (equivalent of the Cancer Worry Scale), the first of its kind in the Spanish language, in order to evaluate it.

10 Jun 2011

German hospital adopts Luminex new diagnostic assay to manage current E.coli outbreak

Luminex Corporation and the Kliniken der Stadt Koln, Institute of Pathology and Institute for Hygiene today announced that Luminex's newly released xTAG Gastrointestinal Pathogen Panel (GPP) is being used successfully as a first-line screen for patients at Kliniken der Stadt Koln suspected of having an E. coli infection.

From Luminex 10 Jun 2011

CMSRU earns Liaison Committee on Medical Education preliminary accreditation

Almost two years after officials announced its creation, Cooper Medical School of Rowan University (CMSRU) has received the go-ahead to recruit students for the charter class - entering in the fall of 2012.

10 Jun 2011

Study links mutations in essential genes with orphan diseases

Mutations in genes essential to survival are behind so-called orphan diseases, explaining in part why these diseases are rare and often deadly, according to a study appearing in The American Journal of Human Genetics.

10 Jun 2011